04-Mar-2026
Download PDF
Aurobindo Pharma
Submission of press release on launch of Pomalidomide Capsules 1 mg 2 mg 3 mg and 4 mg in the US market by Eugia Pharma Specialities LImited wholly owned subsidiary of the Company.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
